FDA panel votes on epidural steroid injections

An FDA advisory committee has met to address concerns about serious adverse effects of epidural steroid injections for pain management.

This follows reports of adverse neurological consequences associated with the treatment, including a number of cases of arachnoiditis following the injections.

But after two days of consultations the committee eventually voted not to issue a strong warning against the general use